메뉴 건너뛰기




Volumn 7, Issue 6, 2006, Pages 699-706

Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation

Author keywords

Adenosine; Adenosine receptors; Asthma; COPD; Inflammation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4' (2 ALKYL) TETRAZOYL DERIVATIVE; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ALLERGEN; CYTOKINE; ENPROFYLLINE; EPI 2010; GLUCOCORTICOID; GW 328267; INTERFERON; INTERLEUKIN 8; RECEPTOR SUBTYPE; THEOPHYLLINE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANTHINE;

EID: 33744810576     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006777435236     Document Type: Review
Times cited : (43)

References (105)
  • 3
    • 33744813597 scopus 로고    scopus 로고
    • National Institutes of Health NH, Lung and Blood Institute., Report No.: NIH Publication No. 97-4051A., Guidelines for the diagnosis and management of asthma: National Institutes of Health, National Heart, Lung and Blood Institute; May 1997
    • National Institutes of Health NH, Lung and Blood Institute., Guidelines for the diagnosis and management of asthma: National Institutes of Health, National Heart, Lung and Blood Institute; May 1997. Report No.: NIH Publication No. 97-4051A.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.